Cargando…

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2

In this study, we examined the role of the miRNA miR-770-5p in cisplatin chemotherapy resistance in ovarian cancer (OVC) patients. miR-770-5p expression was reduced in platinum-resistant patients. Using a 6.128-fold in expression as the cutoff value, miR-770-5p expression served as a prognostic biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Henan, Yu, Xiaotang, Ding, Yanfang, Zhao, Jinyao, Wang, Guang, Wu, Xian, Jiang, Jiyong, Peng, Chun, Guo, Gordon Zhuo, Cui, Shiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288183/ https://www.ncbi.nlm.nih.gov/pubmed/27449101 http://dx.doi.org/10.18632/oncotarget.10736

Ejemplares similares

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)

Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma
por: ZHANG, XINCHEN, et al.
Publicado: (2015)

NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis
por: Zhu, Mingzhe, et al.
Publicado: (2020)

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells
por: Xie, Xiaoque, et al.
Publicado: (2019)

Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer
por: Wu, Han, et al.
Publicado: (2022)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
por: Li, Weijia, et al.
Publicado: (2023)

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
por: Wang, De-Ying, et al.
Publicado: (2020)

MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
por: Cao, Lanqin, et al.
Publicado: (2018)

miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
por: Yang, Shiying, et al.
Publicado: (2020)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
por: Obiedat, Hadeel, et al.
Publicado: (2018)

Down-Regulation of miR-7 in Gastric Cancer Is Associated With Elevated LDH-A Expression and Chemoresistance to Cisplatin
por: Jin, Hui-Fang, et al.
Publicado: (2020)

The involvement of serum exosomal miR-500-3p and miR-770-3p in aging: modulation by calorie restriction
por: Lee, Eun Kyeong, et al.
Publicado: (2017)

ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines
por: Weaver, David A, et al.
Publicado: (2005)

Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells
por: Noyan, Senem, et al.
Publicado: (2019)

MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3
por: Wang, Li, et al.
Publicado: (2020)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism
por: Dou, Lei, et al.
Publicado: (2023)

Circular RNA from Tyrosylprotein Sulfotransferase 2 Gene Inhibits Cisplatin Sensitivity in Head and Neck Squamous Cell Carcinoma by Sponging miR-770-5p and Interacting with Nucleolin
por: Wang, Tianqing, et al.
Publicado: (2023)

The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC
por: Cai, Yang, et al.
Publicado: (2015)

Masses and widths of the $\rho^{\pm,0}$(770)
por: Feuillat, M, et al.
Publicado: (2001)

770 Outcome Results of the Prospective CEA Registry
por: Homsombath, Bounthavy, et al.
Publicado: (2023)

Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613
por: Li, Delong, et al.
Publicado: (2020)

770 preguntas y respuestas : determinaciones bioquímicas : utilidad y valoración clínica
por: Díaz Portillo, Jacobo
Publicado: (2004)

β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
por: LI, QUENTIN Q., et al.
Publicado: (2013)

miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2
por: Liu, Hui-Ning, et al.
Publicado: (2018)

Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients
por: Zazuli, Zulfan, et al.
Publicado: (2019)

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
por: Sestito, Rosanna, et al.
Publicado: (2015)

Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149
por: He, Yuwen, et al.
Publicado: (2020)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
por: Li, Yaming, et al.
Publicado: (2018)

Downregulation of lncRNA MEG3 and miR-770-5p inhibit cell migration and proliferation in Hirschsprung’s disease
por: Li, Hongxing, et al.
Publicado: (2017)

Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase
por: Lee, Hyung Chul, et al.
Publicado: (2017)

A study of rho0(770) production at LEP
por: Edwards, J
Publicado: (1997)

Spondyloarthrites au Sénégal : étude de 770 observations
por: Abba, Abbasse, et al.
Publicado: (2021)

ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine
por: Ulker, Mehmet, et al.
Publicado: (2015)

MiR-7-5p suppresses invasion via downregulation of the autophagy-related gene ATG7 and increases chemoresistance to cisplatin in BCa
por: Wang, Chong, et al.
Publicado: (2022)

FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
por: Zhu, Wei, et al.
Publicado: (2023)

DNA repair endonuclease ERCC1–XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy
por: McNeil, Ewan M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_72srtk8gmiai2bmtdcsdt84o7g